OvaScience CEO and leadership

Theresa McNeely has over 20 years of integrated corporate communications experience spanning investor relations, public relations, marketing communications, and patient advocacy in life sciences companies, including pharmaceutical and biotech, molecular diagnostics, tools, and service providers. She has counseled executive teams on communications strategies around key events, such as international product launches, clinical trial results, strategic redirection, executive transitions, financings, and regulatory decisions. Ms. McNeely was most recently SVP, Investor Relations and Corporate Communications at Akebia Therapeutics. Prior to Akebia, Ms. McNeely was Executive Vice President, Chief Communications Officer at OvaScience and before that, she was Vice President of Corporate Communications at Clinical Data, Inc., a company that was acquired by Forest Laboratories for $1.2 billion. Ms. McNeely has also held management positions at Millennium Pharmaceuticals, EXACT Sciences, and Pyrosequencing. Earlier in her career, Ms. McNeely worked on Wall Street for Allen & Company. She is a member of the Board of Directors for Women in Bio, and an Advisory Board member for Cramer Productions, a creative brand experience agency. Ms. McNeely received her B.S. in Business Administration from Providence College, and an M.S. in Business Communications and Healthcare Communications from Simmons College.